![Ross Patane](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ross Patane
Chief Executive Officer at
GROUP ONE CAPITAL LIMITED
Profile
Rosario Patane is Chief Executive Officer, MD & Director at Group One Capital Ltd. since 2025.
Currently holds the position of Director at Henry Morgan Ltd. Holds the title of Associate Member at the Australian Institute of Co. Directors.
Holds the title of Associate at The Institute of Chartered Accountants in Australia.
Former roles include Non-Executive Chairman at Qbiotics Pty Ltd., Non-Executive Director at Australian Securities & Investments Commission, Independent Non-Executive Director at John Bridgeman Ltd. from 2015 to 2020, Non-Executive Director at Henry Morgan Ltd. (Australia) from 2019 to 2020, Director at Benjamin Hornigold Ltd., Trustee at Queensland Art Gallery & Gallery of Modern Art, and Managing Principal at Crowe Horwath from 2012 to 2018.
Ross Patane active positions
| Companies | Position | Start |
|---|---|---|
| GROUP ONE CAPITAL LIMITED | Chief Executive Officer | 31/10/2025 |
Henry Morgan Ltd.
 Henry Morgan Ltd. Investment Banks/BrokersFinance Provides investment services | Director/Board Member | - |
The Institute of Chartered Accountants in Australia | Corporate Officer/Principal | - |
Australian Institute of Co. Directors
 Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Corporate Officer/Principal | - |
Former positions of Ross Patane
| Companies | Position | End |
|---|---|---|
| JOHN BRIDGEMAN LTD | Director/Board Member | 15/01/2020 |
| HENRY MORGAN LTD | Director/Board Member | 15/01/2020 |
Crowe Horwath
 Crowe Horwath Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Corporate Officer/Principal | 01/01/2018 |
| BENJAMIN HORNIGOLD LIMITED | Director/Board Member | - |
Australian Securities & Investments Commission
 Australian Securities & Investments Commission General GovernmentGovernment Operates as an independent commonwealth government body that enforces company and financial services laws to protect consumers, investors and creditors | Director/Board Member | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
88
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Raptis Group Ltd.
 Raptis Group Ltd. Real Estate DevelopmentFinance Engages in property development | Finance |
Australian Securities & Investments Commission
Australian Securities & Investments Commission General GovernmentGovernment Operates as an independent commonwealth government body that enforces company and financial services laws to protect consumers, investors and creditors | Government |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Commercial Services |
Queensland Art Gallery & Gallery of Modern Art
 Queensland Art Gallery & Gallery of Modern Art Other Consumer ServicesConsumer Services Provincial art museum | Consumer Services |
The Institute of Chartered Accountants in Australia | |
John Bridgeman Ltd.
 John Bridgeman Ltd. Investment ManagersFinance Provides diversified investment management services | Finance |
Henry Morgan Ltd.
Henry Morgan Ltd. Investment Banks/BrokersFinance Provides investment services | Finance |
Qbiotics Pty Ltd.
 Qbiotics Pty Ltd. Qbiotics Pty Ltd. is an Australian life sciences company specializing in the discovery and development of novel cell signalling small molecules. The company is based in Yungaburra, Australia. The company uses phenotypic screening to discover new solutions for challenging medical conditions, with a clinical focus on treatments for cancer and chronic wounds. Its lead oncology drug, tigilanol tiglate, targets solid tumours and is in phase II human clinical development, while a veterinary formulation is marketed as Stelfonta® in the USA and Australia. Qbiotics also has a wound healing drug candidate, EBC 1013, targeting chronic and acute wounds and burns, currently in phase I clinical development for venous leg ulcers. | |
Crowe Horwath
Crowe Horwath Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Henry Morgan Ltd. (Australia)
 Henry Morgan Ltd. (Australia) Financial ConglomeratesFinance Operates as an investment company | Finance |
Benjamin Hornigold Ltd.
 Benjamin Hornigold Ltd. Investment Trusts/Mutual FundsMiscellaneous Functions as a closed-end investment fund or Investment trust | Miscellaneous |
- Stock Market
- Insiders
- Ross Patane
